Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:23 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1129–1152 of 3,553 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Fluids Clear all

Conditions: H. Pylori Infection, Gastric Cancer, Gastritis H Pylori
Interventions: PYTEST® 14C-Urea Capsule Breath Test (at Home), PYTEST® 14C-Urea Capsule Breath Test (Standard Retesting In-Person); Drug
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Shock
Interventions: Fluids; Other
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 1,639 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Chest Pain, Dyspnea, Syncope, Hypotension
Interventions: Point-of-care ultrasound, Usual care; Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Attention Deficit and Disruptive Behavior Disorder, Attention Deficit Disorder With Hyperactivity
Interventions: Not listed
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 6 Years to 17 Years
Enrollment: 347 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1985 – 2017
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cannabis Use, Cannabis Intoxication, Cannabis Use Disorder
Interventions: Biologic testing for THC; Other
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 18 Years to 35 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Diabetes Mellitus, Type 2
Interventions: Inhaled insulin; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 30 Years to 55 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 2
States / cities: Fresno, California • San Antonio, Texas

Conditions: Bowel Cleansing Prior to Colonoscopy
Interventions: FM-601; Drug
Lead sponsor: C.B. Fleet Company, Inc.; Industry
Eligibility: 50 Years and older
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 2
States / cities: Anaheim, California • Omaha, Nebraska

Conditions: Dehydration, Menstruation, Pre-menopause, Peri-menopausal Women, Post-menopausal Women, Hydration
Interventions: placebo beverage, electrolyte beverage; Other
Lead sponsor: PepsiCo Global R&D; Industry
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 2
States / cities: Bradenton, Florida • Valhalla, New York

Conditions: Burn Injury
Interventions: dl-alpha-tocopheryl acetate; Drug
Lead sponsor: Shriners Hospitals for Children; Other
Eligibility: 6 Months to 85 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2021
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Healthy Participants
Interventions: MK-1406 Injection; Combination Product
Lead sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA); Industry
Eligibility: 18 Years to 66 Years
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 4
States / cities: Miami Lakes, Florida • Spartanburg, South Carolina

Conditions: Osteoarthritis
Interventions: Lactated Ringer, Placebo; Drug
Lead sponsor: West Virginia University; Other
Eligibility: 18 Years and older
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Morgantown, West Virginia

Conditions: Bronchopulmonary Dysplasia
Interventions: Chest computed tomography (CT) with angiography, Bronchoscopy with bronchoalveolar lavage, Echocardiography, 24 hour esophageal pH ("potential of hydrogen") - multichannel intraluminal impedance (MII) monitoring (reflux testing); Diagnostic Test
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 1 Month to 1 Year
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Diabetes, Wound Infection, Healthy Volunteers
Interventions: Ceftolozane/tazobactam, Microdialysis Catheter Insertion; Drug · Procedure
Lead sponsor: Hartford Hospital; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Breast Cancer, Pain, Lymphedema Arm
Interventions: The-Optimal-Lymph-Flow; Behavioral
Lead sponsor: University of Missouri, Kansas City; Other
Eligibility: 18 Years to 89 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Glycemic Response
Interventions: Nutritional Supplement; Other
Lead sponsor: Abbott Nutrition; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 97 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 3
States / cities: Jupiter, Florida • Addison, Illinois • Chicago, Illinois

Conditions: Contrast Induced Nephropathy
Interventions: Intravenous Nitroglycerin, IV Fluids; Drug
Lead sponsor: Mt. Sinai Medical Center, Miami; Other
Eligibility: 18 Years and older
Enrollment: 122 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Miami Beach, Florida

Conditions: Neurofibromatosis Type 1 (NF1)
Interventions: Cholecalciferol; Drug
Lead sponsor: University of Utah; Other
Eligibility: 25 Years to 40 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 2
States / cities: Cincinnati, Ohio • Salt Lake City, Utah

Conditions: Ulcerative Colitis, Ileal Pouch
Interventions: Aquamin; Drug
Lead sponsor: Muhammad N Aslam, MD; Other
Eligibility: 18 Years to 80 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Febrile Neutropenia
Interventions: linezolid, vancomycin; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 13 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2002
U.S. locations: 16
States / cities: Los Angeles, California • Springfield, Illinois • The Bronx, New York + 5 more

Conditions: Energy Expenditure in Burn Children, Protein Turnover in Burn Children
Interventions: Use of Stable Isotope to Measure Energy Expenditure and Protein Turnover; Other
Lead sponsor: Shriners Hospitals for Children; Other
Eligibility: 2 Years to 18 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Actinic Keratosis
Interventions: Biafine, Polysporin; Drug
Lead sponsor: Wake Forest University; Other
Eligibility: 50 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Fluid Overload
Interventions: Bioimpedance device; Diagnostic Test
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 6 Years to 21 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Pneumonia, Sinusitis, Bronchitis, Respiratory Disease, Respiratory Tract Infections
Interventions: Lymphatic Pump Osteopathic Manipulative Therapy; Procedure
Lead sponsor: Geisinger Clinic; Other
Eligibility: 65 Years to 100 Years
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Bloomsburg, Pennsylvania

Conditions: Post-Lumbar Puncture Headache
Interventions: Modified Lumbar Puncture; Procedure
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Search by objective public record fields.

Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community-AIM 2

Variation in Fluids Administered in Shock

Impact of Immediate Point-of-Care Ultrasound on Patients With Cardiopulmonary Symptoms in the Emergency Department

Biological Markers in Attention Deficit/Hyperactivity Disorder (ADHD)

Study of an Oral Fluid Testing Approach

To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.

Efficacy Study of Bowel Preparation Before Colonoscopy

Hydration & Female Life Stages

Vitamin E Supplementation in Burn Patients

A Study of Annual Doses of MK-1406/CD388 in Healthy Adults (MK-1406-006/CD388.SQ.2.07)

Does Fluid Replacement From Preoperative NPO Status Improve Postoperative Recovery

Multidimensional Phenotype Classification in Grade 3 Bronchopulmonary Dysplasia

Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections

Advancing Patient Care for Lymphatic Pain and Lymphedema

Study of a Carbohydrate Drink in Adults

Contrast Nephropathy and Nitrates

Vitamin D Supplementation for Adults With Neurofibromatosis Type 1 (NF1)

Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation

Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection

Total Energy Expenditure, Protein Kinetics, and Body Composition in Recovering Burn Children.

Clinical Trial to Evaluate Biafine Cream Versus Standard Care in Subjects With Actinic Keratosis Post Cryotherapy

Using Bioimpedance Analysis to Monitor Fluid Status in Children

How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.

A Prospective Study of a Modified Lumbar Puncture (LP) Procedure That Reduces Post-Lumbar Puncture Headaches (PLPH) in Patients